These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21080205)

  • 1. Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.
    Platts JA; Ermondi G; Caron G; Ravera M; Gabano E; Gaviglio L; Pelosi G; Osella D
    J Biol Inorg Chem; 2011 Mar; 16(3):361-72. PubMed ID: 21080205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness.
    Hambley TW; Battle AR; Deacon GB; Lawrenz ET; Fallon GD; Gatehouse BM; Webster LK; Rainone S
    J Inorg Biochem; 1999 Oct; 77(1-2):3-12. PubMed ID: 10626347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antitumor activity, and chemical properties of silaplatin and related platinum (II) and platinum (IV) complexes derived from beta-silyl amines.
    Anderson WK; Kasliwal R; Houston DM; Wang YS; Narayanan VL; Haugwitz RD; Plowman J
    J Med Chem; 1995 Sep; 38(19):3789-97. PubMed ID: 7562909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(IV) complexes with dipeptide. X-ray crystal structure, 195Pt NMR spectra, and their inhibitory glucose metabolism activity in Candida albicans.
    Watabe M; Kai M; Asanuma S; Yoshikane M; Horiuchi A; Ogasawara A; Watanabe T; Mikami T; Matsumoto T
    Inorg Chem; 2001 Mar; 40(7):1496-500. PubMed ID: 11261956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
    Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
    J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RP-HPLC measurement and QSPR analysis of logP(o/w) values of several Pt(II) complexes.
    Platts JA; Oldfield SP; Reif MM; Palmucci A; Gabano E; Osella D
    J Inorg Biochem; 2006 Jul; 100(7):1199-207. PubMed ID: 16530269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platinum(IV) anticancer complexes.
    Hall MD; Dolman RC; Hambley TW
    Met Ions Biol Syst; 2004; 42():297-322. PubMed ID: 15206106
    [No Abstract]   [Full Text] [Related]  

  • 8. Machine Learning-Based Prediction of Reduction Potentials for Pt
    Vigna V; Cova TFGG; Nunes SCC; Pais AACC; Sicilia E
    J Chem Inf Model; 2024 May; 64(9):3733-3743. PubMed ID: 38683970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.
    Oldfield SP; Hall MD; Platts JA
    J Med Chem; 2007 Oct; 50(21):5227-37. PubMed ID: 17900102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the hydrophobicity of platinum(IV) complexes based on molecular surface properties.
    Zou JW; Cui GY; Huang M; Hu GX; Jiang YJ
    J Inorg Biochem; 2021 Apr; 217():111373. PubMed ID: 33578249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?
    Zanellato I; Bonarrigo I; Colangelo D; Gabano E; Ravera M; Alessio M; Osella D
    J Inorg Biochem; 2014 Nov; 140():219-27. PubMed ID: 25171667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses, crystal structure and cytotoxicity of diamine platinum(II) complexes containing maltol.
    Carland M; Tan KJ; White JM; Stephenson J; Murray V; Denny WA; McFadyen WD
    J Inorg Biochem; 2005 Aug; 99(8):1738-43. PubMed ID: 16038978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.
    Mügge C; Rothenburger C; Beyer A; Görls H; Gabbiani C; Casini A; Michelucci E; Landini I; Nobili S; Mini E; Messori L; Weigand W
    Dalton Trans; 2011 Mar; 40(9):2006-16. PubMed ID: 21212880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
    Yap SQ; Chin CF; Hong Thng AH; Pang YY; Ho HK; Ang WH
    ChemMedChem; 2017 Feb; 12(4):300-311. PubMed ID: 28028938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DFT-based reactivity and QSPR studies of platinum (IV) anticancer drugs.
    Sarmah P
    J Mol Graph Model; 2020 Nov; 100():107682. PubMed ID: 32739639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
    Yoo J; Do Y
    Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rational design of anticancer platinum complexes: the importance of the structure-activity relationship.
    Montaña AM; Batalla C
    Curr Med Chem; 2009; 16(18):2235-60. PubMed ID: 19519389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches.
    Tetko IV; Varbanov HP; Galanski MS; Talmaciu M; Platts JA; Ravera M; Gabano E
    J Inorg Biochem; 2016 Mar; 156():1-13. PubMed ID: 26717258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.